Latest Insider Transactions at Resmed Inc (RSMDF)
This section provides a real-time view of insider transactions for Resmed Inc (RSMDF). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RESMED INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RESMED INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.27%
|
$323,475
$57.76 P/Share
|
|
Dec 05
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,500
-1.5%
|
$343,500
$229.81 P/Share
|
|
Nov 28
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Bona fide gift
|
Direct |
7,300
-6.79%
|
-
|
|
Nov 25
2022
|
David Pendarvis Chief Administrative Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
683
+0.63%
|
$99,718
$146.34 P/Share
|
|
Nov 23
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,911
-6.08%
|
$1,548,064
$224.4 P/Share
|
|
Nov 23
2022
|
David Pendarvis Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,389
+9.83%
|
-
|
|
Nov 23
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,239
-7.07%
|
$7,445,536
$224.4 P/Share
|
|
Nov 23
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,115
+10.66%
|
-
|
|
Nov 23
2022
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
4,318
-20.54%
|
$967,232
$224.4 P/Share
|
|
Nov 23
2022
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
BUY
Grant, award, or other acquisition
|
Direct |
7,288
+25.74%
|
-
|
|
Nov 23
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
19,425
-26.62%
|
$4,351,200
$224.4 P/Share
|
|
Nov 23
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Grant, award, or other acquisition
|
Direct |
32,795
+31.0%
|
-
|
|
Nov 23
2022
|
Brett Sandercock Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,577
+10.76%
|
-
|
|
Nov 23
2022
|
Justin Leong Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,924
+9.4%
|
-
|
|
Nov 22
2022
|
Justin Leong Chief Product Officer |
SELL
Open market or private sale
|
Direct |
3,777
-5.94%
|
$864,933
$229.5 P/Share
|
|
Nov 22
2022
|
Justin Leong Chief Product Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+19.09%
|
$855,000
$57.76 P/Share
|
|
Nov 21
2022
|
Lucile Blaise President, Sleep & RC Business |
SELL
Payment of exercise price or tax liability
|
Direct |
267
-1.32%
|
$59,808
$224.4 P/Share
|
|
Nov 16
2022
|
Jan De Witte Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+15.51%
|
-
|
|
Nov 16
2022
|
John Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+35.06%
|
-
|
|
Nov 16
2022
|
Desney Tan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+35.06%
|
-
|
|
Nov 16
2022
|
Richard Sulpizio Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+6.98%
|
-
|
|
Nov 16
2022
|
Ronald R Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+5.11%
|
-
|
|
Nov 16
2022
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+11.56%
|
-
|
|
Nov 16
2022
|
Harjit Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+13.38%
|
-
|
|
Nov 16
2022
|
Carol Burt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+35.06%
|
-
|
|
Nov 16
2022
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,122
+0.62%
|
-
|
|
Nov 15
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.35%
|
$1,271,200
$224.64 P/Share
|
|
Nov 15
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.33%
|
$323,475
$57.76 P/Share
|
|
Nov 15
2022
|
Lucile Blaise President, Sleep & RC Business |
SELL
Open market or private sale
|
Direct |
169
-2.25%
|
$38,025
$225.18 P/Share
|
|
Nov 15
2022
|
Lucile Blaise President, Sleep & RC Business |
BUY
Exercise of conversion of derivative security
|
Direct |
516
+6.43%
|
$116,100
$225.18 P/Share
|
|
Nov 15
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
11,280
-21.92%
|
$2,504,160
$222.07 P/Share
|
|
Nov 15
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
18,032
+13.95%
|
$1,045,856
$58.24 P/Share
|
|
Nov 11
2022
|
Harjit Gill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
41
-0.66%
|
$9,225
$225.18 P/Share
|
|
Nov 11
2022
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
898
-3.11%
|
$202,050
$225.18 P/Share
|
|
Nov 11
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,630
-0.69%
|
$1,941,750
$225.18 P/Share
|
|
Nov 11
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Payment of exercise price or tax liability
|
Direct |
1,705
-2.46%
|
$383,625
$225.18 P/Share
|
|
Nov 11
2022
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.07%
|
$28,800
$225.18 P/Share
|
|
Nov 11
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,066
-0.35%
|
$239,850
$225.18 P/Share
|
|
Nov 10
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
4,880
-100.0%
|
$1,073,600
$220.83 P/Share
|
|
Nov 10
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
1,000
+17.01%
|
-
|
|
Nov 10
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
1,000
-19.65%
|
-
|
|
Nov 07
2022
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,000
-3.63%
|
$848,000
$212.02 P/Share
|
|
Nov 03
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,545
-1.49%
|
$332,175
$215.23 P/Share
|
|
Oct 31
2022
|
Peter C Farrell Director |
SELL
Bona fide gift
|
Direct |
4,550
-2.49%
|
-
|
|
Oct 31
2022
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
9,050
-4.71%
|
$2,000,050
$221.98 P/Share
|
|
Oct 17
2022
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,675
-1.33%
|
$1,214,450
$214.58 P/Share
|
|
Oct 17
2022
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,675
+1.31%
|
$323,475
$57.76 P/Share
|
|
Oct 14
2022
|
Robert Andrew Douglas Special Advisor |
SELL
Open market or private sale
|
Direct |
11,355
-24.45%
|
$2,441,325
$215.09 P/Share
|
|
Oct 14
2022
|
Robert Andrew Douglas Special Advisor |
BUY
Exercise of conversion of derivative security
|
Direct |
18,033
+15.2%
|
$1,045,914
$58.24 P/Share
|
|
Oct 03
2022
|
David Pendarvis Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
1,545
-1.47%
|
$339,900
$220.19 P/Share
|